Logo Prima Biomed

Company Calendar

  • November 16th, 2017

     

    ICI Europe - 3rd Annual Summit, Delivering Maximum Clinical Benefit Through Immune
    Checkpoint Modulation, Munich, Germany

    Frédéric Triebel is speaking about “Combination Strategies for LAG-3Ig (IMP321) With Either Chemotherapy or Anti-PD-1 Therapy” at 1:15 PM.

  • November 17th, 2017

     

    Annual General Meeting in November 2017, Sydney, Australia

     

  • November 21st, 2017

     

    Twilight Investor Presentation, The Boardroom, Level 14, 90 Collins Street, Melbourne, Australia

     

    Briefing by Prima Biomed CEO, Marc Voigt at 4.30PM

     

  • November 24th, 2017

     

    Kinghorn Cancer Centre, Darlinghurst, Sydney, Australia


    Frédéric Triebel is speaking about “LAG-3, Identification & Validation Of Next Generation Checkpoint Pathway: Combination Strategies for LAG-3Ig (IMP321 or Eftilagimod Alpha) With Either Chemotherapy or Anti-PD-1 Therapy in Oncology” at 10 AM.

     

  • January 8-11, 2018

     

    36th Annual J.P. Morgan Health Care Investor Conference, San Francisco, California, USA

    http://bit.ly/2xBvH7B

     

  • March 19-23, 2018

     

    3rd Annual Immuno-Oncology Summit Europe, Hilton London Canary Wharf, London, UK

     

    http://www.immuno-oncologyeurope.com/

     

  • June 1-5, 2018

     

    2018 ASCO Annual Meeting, McCormick Place, Chicago, IL, USA

    https://am.asco.org/